Trials / Conditions / Stage II Renal Pelvis Cancer AJCC v8
Stage II Renal Pelvis Cancer AJCC v8
4 registered clinical trials studyying Stage II Renal Pelvis Cancer AJCC v8 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remov NCT06661720 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary NCT04398368 | Mayo Clinic | Phase 2 |
| Completed | Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Partici NCT03617913 | Mayo Clinic | Phase 2 |
| Completed | Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer NCT00749892 | M.D. Anderson Cancer Center | Phase 2 |